Charles River Laboratories International (CRL) Change in Receivables (2009 - 2025)

Charles River Laboratories International's Change in Receivables history runs 17 years deep, the most recent figure standing at -$27.6 million for Q4 2025.

• In Q4 2025, Change in Receivables fell 734.27% year-over-year to -$27.6 million; the TTM figure through Dec 2025 stood at -$35.7 million (down 65.36% YoY), while the FY2025 annual figure was -$35.7 million, down 65.36% from the prior year.
• Change in Receivables for Q4 2025 stood at -$27.6 million, down from -$26.6 million in the prior quarter.
• The five-year high for Change in Receivables was $59.7 million in Q2 2022, with the low at -$27.6 million in Q4 2025.
• The 5-year median for Change in Receivables is $3.8 million (2021), against an average of $7.7 million.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables soared 1135.05% in 2022, then slumped 734.27% in 2025.
• Charles River Laboratories International's Change in Receivables stood at -$9.0 million in 2021, then plunged by 163.41% to -$23.6 million in 2022, then retreated by 8.68% to -$25.6 million in 2023, then surged by 87.09% to -$3.3 million in 2024, then plunged by 734.27% to -$27.6 million in 2025.
• Business Quant data shows CRL's Change in Receivables at -$27.6 million in Q4 2025, -$26.6 million in Q3 2025, and -$10.9 million in Q2 2025.